Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Aringer

Showing results (141-150 of 216) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Characterization and analysis of the proximal Janus kinase 3 promoterMartin Aringer, Sigrun R Hofmann, David M Frucht, et al.
Zeitschrift Fur Rheumatologie|May 16, 2019
[Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care]Gernot Keyßer, Christoph G O Baerwald, Maren Sieburg, et al.
The Journal of Rheumatology|July 26, 2002
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formationJohannes Grisar, Peter M Bernecker, Martin Aringer, et al.
Annals of the Rheumatic Diseases|November 4, 2018
Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus MeetingJohanna Mucke, Hans-Joachim Anders, Martin Aringer, et al.
Annals of Hematology|January 12, 2024
VEXAS syndrome: complete molecular remission after hypomethylating therapyKatja Sockel, Katharina Götze, Christina Ganster, et al.
Zeitschrift Fur Rheumatologie|June 6, 2023
[With RheMIT rheumatology centers can participate in the German national database-Expansion of the long-term rheumatological documentation]Johanna Callhoff, Martin Feuchtenberger, Kirsten Karberg, et al.
Rheumatology (Oxford, England)|October 31, 2021
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extensionJohn H Stone, Helen Spotswood, Sebastian H Unizony, et al.
Pageof 22

Showing results (141-150 of 216) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Characterization and analysis of the proximal Janus kinase 3 promoterMartin Aringer, Sigrun R Hofmann, David M Frucht, et al.
Zeitschrift Fur Rheumatologie|May 16, 2019
[Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care]Gernot Keyßer, Christoph G O Baerwald, Maren Sieburg, et al.
The Journal of Rheumatology|July 26, 2002
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formationJohannes Grisar, Peter M Bernecker, Martin Aringer, et al.
Annals of the Rheumatic Diseases|November 4, 2018
Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus MeetingJohanna Mucke, Hans-Joachim Anders, Martin Aringer, et al.
Annals of Hematology|January 12, 2024
VEXAS syndrome: complete molecular remission after hypomethylating therapyKatja Sockel, Katharina Götze, Christina Ganster, et al.
Zeitschrift Fur Rheumatologie|June 6, 2023
[With RheMIT rheumatology centers can participate in the German national database-Expansion of the long-term rheumatological documentation]Johanna Callhoff, Martin Feuchtenberger, Kirsten Karberg, et al.
Rheumatology (Oxford, England)|October 31, 2021
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extensionJohn H Stone, Helen Spotswood, Sebastian H Unizony, et al.
Pageof 22